https://www.selleckchem.com/pr....oducts/kartogenin.ht
in patients with tumors demonstrating mucinous, signet ring cell, or medullary differentiation.Endometrial carcinoma (EC), as described by Bokhman, has historically been classified as Type I (low-grade, hormone-dependant, young patients, good prognosis) or Type II (high-grade, hormone-independent, older patients, poor prognosis). This classification is no longer pragmatic, however, as EC is a much more heterogeneous disease. Four molecular subtypes of EC were identified by The Cancer Genome Atlas (TCGA), and subsequent studies have d
Like
Comment
Share
